Vir Biotechnology Inc (NASDAQ:VIR) shares, rose in value, with the stock price down by -0.30% to the previous day’s close as strong demand from buyers drove the stock to $6.57.
Actively observing the price movement in the recent trading, the stock is buoying the session at $6.59, falling within a range of $6.4 and $6.59. The value of beta (5-year monthly) is 1.166. Referring to stock’s 52-week performance, its high was $14.45, and the low was $6.53. On the whole, VIR has fluctuated by -28.59% over the past month.
With the market capitalization of Vir Biotechnology Inc currently standing at about $901.03 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-25.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 8.59M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VIR’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of VIR currently trading nearly -10.58% and -26.05% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 29.62, while the 7-day volatility ratio is showing 4.65% which for the 30-day chart, stands at 6.14%. Furthermore, Vir Biotechnology Inc (VIR)’s beta value is 1.13, and its average true range (ATR) is 0.43.
A comparison of Vir Biotechnology Inc (VIR) with its peers suggests the former has fared considerably weaker in the market. VIR showed an intraday change of -0.30% in today’s session so far, and over the past year, it shrunk by -34.30%%.
Data on historical trading for Vir Biotechnology Inc (NASDAQ:VIR) indicates that the trading volumes over the past 10 days have averaged 1.38 and over the past 3 months, they’ve averaged 2.07 million. According to company’s latest data on outstanding shares, there are 136.96 million shares outstanding.
Nearly 36.28% of Vir Biotechnology Inc’s shares belong to company insiders and institutional investors own 51.31% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.88 million shares as on 2025-03-14, resulting in a short ratio of 6.79. According to the data, the short interest in Vir Biotechnology Inc (VIR) stood at 935.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 7.67 million. The stock has fallen by -10.49% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VIR stock heading into the next quarter.
